Back to search

Effects of phencyclidine (PCP) and MK 801 on the EEGq in the prefrontal cortex of conscious rats; antagonism by clozapine, and antagonists of AMPA‐, α1‐ and 5‐HT2A‐receptors

Data up to Jan 2025

Published2002
Citations61
References98

Total Citations Per Year

Abstract

References (98)

Implications of Normal Brain Development for the Pathogenesis of Schizophrenia

1987 • 3,683 citations

Thalamocortical Oscillations in the Sleeping and Aroused Brain

1993 • 3,483 citations

Physiologic Dysfunction of Dorsolateral Prefrontal Cortex in Schizophrenia

1986 • 2,026 citations

The Neuropsychopharmacology of Phencyclidine From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia

1999 • 1,300 citations

Basic mechanisms of cerebral rhythmic activities

1990 • 1,135 citations

Gating and Habituation of the Startle Reflex in Schizophrenic Patients

1992 • 1,030 citations

Prefrontal Phase Locking to Hippocampal Theta Oscillations

2005 • 1,004 citations

The current status of the dopamine hypothesis of schizophrenia

1988 • 962 citations

Study of a New Schizophrenomimetic Drug—Sernyl

1959 • 922 citations

Intracellular analysis of relations between the slow (< 1 Hz) neocortical oscillation and other sleep rhythms of the electroencephalogram

1993 • 893 citations

Psychopharmacology: The Fourth Generation of Progress

1995 • 842 citations

D1 receptors in prefrontal cells and circuits

2000 • 804 citations

Neuronal activities in brain-stem cholinergic nuclei related to tonic activation processes in thalamocortical systems

1990 • 779 citations

Synchronization between prefrontal and posterior association cortex during human working memory

1998 • 732 citations

Ketamine-Induced Exacerbation of Psychotic Symptoms and Cognitive Impairment in Neuroleptic-Free Schizophrenics

1997 • 670 citations

NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy Volunteers

1996 • 667 citations

Serotonin model of schizophrenia: emerging role of glutamate mechanisms

2000 • 520 citations

Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance

2000 • 498 citations

Functional Brain Imaging Studies of Cortical Mechanisms for Memory

1995 • 492 citations

Serotonin Induces Excitatory Postsynaptic Potentials in Apical Dendrites of Neocortical Pyramidal Cells

1997 • 487 citations

Phencyclidine-induced psychosis

1978 • 482 citations

NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine

1996 • 450 citations

Fast oscillations (20-40 Hz) in thalamocortical systems and their potentiation by mesopontine cholinergic nuclei in the cat.

1991 • 449 citations

Ketamine activates psychosis and alters limbic blood flow in schizophrenia

1995 • 438 citations

Enduring Cognitive Deficits and Cortical Dopamine Dysfunction in Monkeys After Long-Term Administration of Phencyclidine

1997 • 401 citations

Corticolimbic Dopamine Neurotransmission Is Temporally Dissociated from the Cognitive and Locomotor Effects of Phencyclidine

1998 • 368 citations

Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release

1999 • 351 citations

Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response.

1994 • 334 citations

Psychopathology and the Brain

1992 • 325 citations

Subchronic Phencyclidine Administration Reduces Mesoprefrontal Dopamine Utilization and Impairs Prefrontal Cortical-Dependent Cognition in the Rat

1997 • 320 citations

The N-methyl-d-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias

1995 • 306 citations

Cholinergic and noradrenergic modulation of the slow (approximately 0.3 Hz) oscillation in neocortical cells

1993 • 288 citations

5-HT1A and 5-HT2A Receptor mRNAs and Binding Site Densities Are Differentially Altered in Schizophrenia

1996 • 287 citations

Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia

2000 • 279 citations

Neurotransmitter Receptors in Frontal Cortex of Schizophrenics

1979 • 249 citations

On the Plausibility of “The Neurodevelopmental Hypothesis” of Schizophrenia

1996 • 240 citations

Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia

1995 • 220 citations

5-HT2A receptor or α1-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex

1999 • 218 citations

Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine

1998 • 214 citations

The NMDA Antagonist Model for Schizophrenia: Promise and Pitfalls

1998 • 207 citations

Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs

2000 • 206 citations

Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia

2000 • 206 citations

M100907, a Serotonin 5-HT2A Receptor Antagonist and Putative Antipsychotic, Blocks Dizocilpine-Induced Prepulse Inhibition Deficits in Sprague–Dawley and Wistar Rats

1999 • 203 citations

Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release

1998 • 202 citations

Clozapine Blunts N-Methyl-d-Aspartate Antagonist-Induced Psychosis: A Study with Ketamine

1997 • 197 citations

Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine

1995 • 194 citations

Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: Identification of two naturally occurring receptor variants and association analysis in schizophrenia

1996 • 193 citations

The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity

1984 • 181 citations

Cholinergic Excitation of Septohippocampal GABA But Not Cholinergic Neurons: Implications for Learning and Memory

2000 • 179 citations

Subchronic Phencyclidine Administration Increases Mesolimbic Dopaminergic System Responsivity and Augments Stress- and Psychostimulant-Induced Hyperlocomotion

1998 • 162 citations

Positive association between a DNA sequence variant in the serotonin 2A receptor gene and schizophrenia

1996 • 148 citations

Glutamatergic Regulation of Basal and Stimulus‐Activated Dopamine Release in the Prefrontal Cortex

1998 • 145 citations

LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.

1996 • 140 citations

Regional frontal abnormalities in schizophrenia: a quantitative gray matter volume and cortical surface size study

2000 • 135 citations

Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine

1996 • 132 citations

Comparison of Phencyclidine Hydrochloride (Sernyl) with Other Drugs

1962 • 128 citations

Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5-HT2A receptors

1995 • 121 citations

Effect of phenycyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study

1994 • 120 citations

The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat

1995 • 118 citations

Decreased frontal cortical serotonin2A receptors in schizophrenia

1996 • 109 citations

Excitation of interneurons in piriform cortex by 5-hydroxytryptamine: Blockade by MDL 100,907, a highly selective 5-HT2A receptor antagonist

1994 • 98 citations

Prefrontal cortical involvement in phencyclidine-induced activation of the mesolimbic dopamine system: behavioral and neurochemical evidence

1998 • 96 citations

Dissimilar patterns of degeneration in brain following four different addictive stimulants

1993 • 95 citations

2,3‐Benzodiazepines (GYKI 52466 and Analogs): Negative Allosteric Modulators of AMPA Receptors

1996 • 95 citations

Competitive and noncompetitive NMDA antagonists induce similar limbic degeneration

1994 • 95 citations

MK-801 neurotoxicity in male mice: histologic effects and chronic impairment in spatial learning

1996 • 87 citations

Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission

1999 • 83 citations

Relation between hippocampal γ waves and behavioral disturbances induced by phencyclidine and methamphetamine

2000 • 83 citations

S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: II. Functional profile in comparison to clozapine and haloperidol.

1998 • 82 citations

Serotonin2 receptor-mediated excitation of interneurons in piriform cortex: Antagonism by atypical antipsychotic drugs

1994 • 79 citations

Therapeutic Implications of the Hyperglutamatergic Effects of NMDA Antagonists

1999 • 71 citations

Ventral tegmental area 5-HT receptors: mesolimbic dopamine release and behavioural studies

1995 • 68 citations

M100907 and Clozapine, but not Haloperidol or Raclopride, Prevent Phencyclidine-Induced Blockade of NMDA Responses in Pyramidal Neurons of the Rat Medial Prefrontal Cortical Slice

1998 • 66 citations

Cognition-enhancing drugs increase stimulated hippocampal theta rhythm amplitude in the urethane-anesthetized rat.

1999 • 64 citations

Serotonin2 receptors and the serotonin transporter in the schizophrenic brain

1995 • 60 citations

Abnormalities in 5-HT2A receptor mRNA expression in frontal cortex of chronic elderly schizophrenics with varying histories of neuroleptic treatment

2000 • 51 citations

Cognitive and AI models of reasoning

1998 • 50 citations

Increased startle responding in rats treated with phencyclidine.

1984 • 39 citations

Contrasting EEG profiles elicited by antipsychotic agents in the prefrontal cortex of the conscious rat: antagonism of the effects of clozapine by modafinil

1999 • 39 citations

Indoleamine and the phenethylamine hallucinogens: mechanisms of psychotomimetic action

1998 • 39 citations

Acute behavioral effects of phencyclidine on rhesus monkey performance in an operant test battery

1995 • 38 citations

Altered consciousness states and endogenous psychoses: a common molecular pathway?

1997 • 36 citations

Serotonin-dependent maintenance of spatial performance and electroencephalography activation after cholinergic blockade: effects of serotonergic receptor antagonists

1999 • 36 citations

Cortical and hippocampal EEG power spectra in animal models of schizophrenia produced with methamphetamine, cocaine, and phencyclidine

1997 • 35 citations

Ayahoasca: an experimental psychosis that mirrors the transmethylation hypothesis of schizophrenia

1999 • 34 citations

Amphetamine-induced activation of forebrain EEG is prevented by noradrenergic β-receptor blockade in the halothane-anesthetized rat

2000 • 27 citations

Phencyclidine produces changes in NMDA and kainate receptor binding in rat hippocampus over a 48-hour time course

1996 • 18 citations

Some central effects of GYKI 52466, a non-competitive AMPA receptor antagonist.

1995 • 18 citations

Electroencephalographic (EEG), EEG power spectra, and behavioral correlates in rats given phencyclidine

1986 • 17 citations

Hippocampal theta rhythm in anesthetized rats

1999 • 16 citations

Biochemical and behavioural consequences of interactions between dopaminergic and noradrenergic systems in rat prefrontal cortex

1992 • 14 citations

Antagonism of a PCP Drug Discrimination by Hallucinogens and Related Drugs

2000 • 13 citations

Differential antagonistic effects of haloperidol on excitatory responses of cortical neurones to phenylephrine, noradrenaline and dopamine

1983 • 12 citations

Pharmacokinetic‐pharmacodynamic modelling in the early development phase of anti‐psychotics: a comparison of the effects of clozapine, S 16924 and S 18327 in the EEG model in rats

2001 • 12 citations

Changes in dopamine D2 and GluR-1 glutamate receptor mRNAs in the rat brain after treatment with phencyclidine.

1995 • 8 citations

5-HT2 receptors are partially involved in the relationship between renin release and delta relative power

1996 • 8 citations

Age-related variation of EEG responses to clonidine, prazosin and yohimbine in rats.

1987 • 6 citations

Introduction: Neuroimaging of Cognitive Processes

1997 • 5 citations

Cited By (0)

Loading...